Papillary thyroid carcinoma discovered in a patient on semaglutide therapy for metabolic syndrome: a case presentation and review of current evidence
Researchers report a case of papillary thyroid carcinoma (PTC) discovered incidentally in a patient with metabolic syndrome and obesity after several years of semaglutide treatment. The patient underwent thyroidectomy, and pathology confirmed a unifocal classic variant PTC. The study notes that while this case highlights an important clinical scenario, it does not provide evidence of causation, and current human data continues to support the safety of semaglutide regarding thyroid cancer risk.
What to check after reading
This case is an incidental finding and does not prove semaglutide causes thyroid cancer; current evidence supports its safety.
Source
Calendar dates show when a case was added or scheduled. For event dates, check the original source.